Domov › Kardiovaskulárne ochorenia › Oklahoma
Klinické štúdie Kardiovaskulárne ochorenia v štáte Oklahoma
11 štúdií pre Kardiovaskulárne ochorenia hľadá účastníkov v zariadeniach v štáte Oklahoma.
Mestá v štáte Oklahoma
Oficiálny text štúdie (anglicky)
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- Oklahoma Heart Institute, Tulsa
Prebieha nábor
Vek 18 až 85 · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT07214376EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Tekton Research Oklahoma City, Oklahoma City
- South Oklahoma Heart Research Group, Oklahoma City
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07064473Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- South Oklahoma Heart Research, LLC, Oklahoma City
Prebieha náborFáza 4
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT06909565Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Edmond
- Clinical Trial Site, Moore
- Clinical Trial Site, Norman
- a 1 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 9. 2026 · NCT07181109Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
- Integris Baptist Medical Center, Oklahoma City
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT03242642A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Oklahoma City
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 24. 8. 2026 · NCT07000357OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Alliance for Multispecialty Research, Norman
Prebieha náborFáza 3
Vek 50 až 105 · Všetky pohlavia · Aktualizované 21. 8. 2026 · NCT07136012Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Integris Baptist Medical Center, Oklahoma City
- Oklahoma Heart Institute at Utica, Tulsa
- Saint Francis Hospital, Tulsa
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 10. 6. 2026 · NCT06526195The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- Oklahoma Heart Institute Hospital, Tulsa
- Saint Francis Hospital,, Tulsa
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 13. 4. 2026 · NCT03142152MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
- University of Oklahoma Health Science Center, Oklahoma City
Prebieha nábor
Vek 18 až 80 · Všetky pohlavia · Aktualizované 11. 9. 2025 · NCT06271590MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
- Oklahoma University Health (OU Health), Oklahoma City
Prebieha nábor
Vek 18 až 110 · Všetky pohlavia · Aktualizované 25. 2. 2025 · NCT05908331Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.